Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluocinonide 0.05% Oral Gel for Oral Lichen Planus
NCT06135805Completed
- Sponsor
- University of Catania
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in oral lichen planus (OLP) comparing Fluocinonide with Placebo (2 arms). Primary endpoint: Assessment of signs at 3 months. Started Aug 2023; status: completed.
02
Drugs
fluocinonide
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06135805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135805.